Venetoclax–azacitidine as a bridge to transplant in pediatric relapsed/refractory acute myeloid leukemia: A real-world experience

Background: Survival outcomes in pediatric acute myeloid leukemia (AML) have improved significantly; however, prognosis for relapsed or refractory (R/R) disease remains dismal. This study evaluates real-world outcomes of Venetoclax-Azacytidine (Ven–Aza) as a bridge to transplant in children with R/R...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Sunisha Arora, Anuj Singh, Sohini Chakraborty, Vaibhav Chadha, Satyendra Batra, Parminder Pal Singh, Neha Rastogi Panda, Shrinidhi Nathany, Madhur Arora, Anusha Swaminathan, Surbhi Pokhriyal, Aastha Gupta, Surbhi Singh, Bharti Sharma, Rahul Bhargava, Vikas Dua
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2026-06-01
Colecção:	Pediatric Hematology Oncology Journal
Assuntos:	Pediatric AML Azacytidine Venetoclax Salvage
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2468124526000355
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!